Logo image of ITMR

Itamar Medical Ltd (ITMR) Stock Fundamental Analysis

USA - NASDAQ:ITMR - ADR

30.87
+0.25 (+0.82%)
Last: 12/15/2021, 8:36:08 PM
30.85
-0.02 (-0.06%)
After Hours: 12/15/2021, 8:36:08 PM
Fundamental Rating

2

Overall ITMR gets a fundamental rating of 2 out of 10. We evaluated ITMR against 189 industry peers in the Health Care Equipment & Supplies industry. ITMR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ITMR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ITMR has reported negative net income.
ITMR Yearly Net Income VS EBIT VS OCF VS FCFITMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA -20.71%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ITMR Yearly ROA, ROE, ROICITMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 -100 -200 -300

1.3 Margins

Industry RankSector Rank
OM -35.74%
PM (TTM) -41.66%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ITMR Yearly Profit, Operating, Gross MarginsITMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

ITMR has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ITMR has been reduced compared to a year ago.
ITMR Yearly Shares OutstandingITMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M
ITMR Yearly Total Debt VS Total AssetsITMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 20M 40M 60M

2.2 Solvency

An Altman-Z score of 275.25 indicates that ITMR is not in any danger for bankruptcy at the moment.
ITMR has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 275.25
ROIC/WACCN/A
WACCN/A
ITMR Yearly LT Debt VS Equity VS FCFITMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 4.12 indicates that ITMR has no problem at all paying its short term obligations.
A Quick Ratio of 3.78 indicates that ITMR has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.12
Quick Ratio 3.78
ITMR Yearly Current Assets VS Current LiabilitesITMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

ITMR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.67%.
Looking at the last year, ITMR shows a very strong growth in Revenue. The Revenue has grown by 33.79%.
The Revenue has been growing by 19.54% on average over the past years. This is quite good.
EPS 1Y (TTM)-100.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-149.19%
Revenue 1Y (TTM)33.79%
Revenue growth 3Y25.62%
Revenue growth 5Y19.54%
Sales Q2Q%23.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ITMR Yearly Revenue VS EstimatesITMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ITMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ITMR Price Earnings VS Forward Price EarningsITMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -859.6
ITMR Per share dataITMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ITMR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Itamar Medical Ltd

NASDAQ:ITMR (12/15/2021, 8:36:08 PM)

After market: 30.85 -0.02 (-0.06%)

30.87

+0.25 (+0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-16 2021-11-16
Earnings (Next)03-01 2022-03-01/bmo
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.09B
Revenue(TTM)50.88M
Net Income(TTM)-21192000
Analysts85
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 257.28
P/FCF N/A
P/OCF N/A
P/B 177.05
P/tB N/A
EV/EBITDA -859.6
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.12
BVpS0.17
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -35.74%
PM (TTM) -41.66%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.12
Quick Ratio 3.78
Altman-Z 275.25
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-149.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.79%
Revenue growth 3Y25.62%
Revenue growth 5Y19.54%
Sales Q2Q%23.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Itamar Medical Ltd / ITMR FAQ

What is the ChartMill fundamental rating of Itamar Medical Ltd (ITMR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ITMR.


What is the valuation status for ITMR stock?

ChartMill assigns a valuation rating of 0 / 10 to Itamar Medical Ltd (ITMR). This can be considered as Overvalued.


What is the profitability of ITMR stock?

Itamar Medical Ltd (ITMR) has a profitability rating of 1 / 10.


Can you provide the financial health for ITMR stock?

The financial health rating of Itamar Medical Ltd (ITMR) is 6 / 10.